SCHEMBL111448

SCHEMBL111448

CN(C)Cn1cnc2ccc(C(=O)N3CCN(C(=O)O)CC3)cc21

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 12/20 0.46
HRH3 Q9Y5N1 1/20 0.43
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
TNKS O95271 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
PRSS1 P07477 1/20 0.39
MGLL Q99685 1/20 0.38
ACSS2 Q9NR19 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2129926 0.85 MEN1 (0.47) HPGDALDH1A1MEN1KMT2AGAA
SCHEMBL110178 0.76 HPGD (0.51) HPGDALDH1A1MEN1KMT2AGAA
SCHEMBL10268215 0.72 NPC1 (0.46) HPGDALDH1A1MAPTPOLBACSS2
SCHEMBL4291062 0.70 GPR119 (0.42) HPGDHRH3TNKSTNKS2F2
SCHEMBL3838757 0.67 FGFR1 (0.56) HPGDALDH1A1MEN1KMT2AF2
SCHEMBL20733066 0.67 HPGD (0.59) HPGDALDH1A1SMN1; SMN2
SCHEMBL18783301 0.66 HPGD (0.61) HPGDALDH1A1MGLL
SCHEMBL1376416 0.65 GPR183 (0.53) HPGDALDH1A1GAAMAPTKDM4E
SCHEMBL31321944 0.65 FGFR1 (0.47) HPGDALDH1A1MEN1KMT2AGAA
SCHEMBL20732997 0.65 FGFR1 (0.64) HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424843-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES Novartis AG (CH) 2012-03-07 EP disclosed
WO-2010125402-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2010-11-04 WO disclosed